Holen Sie sich die Stockscreener-App
0.62
5.48%
0.018
Schlusskurs vom Vortag:
$0.602
Offen:
$0.6
24-Stunden-Volumen:
327.22K
Relative Volume:
2.06
Marktkapitalisierung:
$12.86M
Einnahmen:
$43.86M
Nettoeinkommen (Verlust:
$-37.43M
KGV:
-0.3074
EPS:
-2.0172
Netto-Cashflow:
$-12.50M
1W Leistung:
+12.37%
1M Leistung:
-0.95%
6M Leistung:
-35.20%
1J Leistung:
-8.37%
1-Tages-Spanne:
$0.5945
$0.67
1-Wochen-Bereich:
$0.5596
$0.67
52-Wochen-Spanne:
$0.5012
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Firmenname
Trinity Biotech Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare TRIB vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.635 | 12.19M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
86.64 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.20 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.82 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-10-23 | Herabstufung | Craig Hallum | Buy → Hold |
| 2015-09-03 | Eingeleitet | Raymond James | Outperform |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2008-07-22 | Bestätigt | Roth Capital | Buy |
| 2008-03-17 | Bestätigt | Roth Capital | Buy |
| 2007-12-10 | Bestätigt | Roth Capital | Buy |
| 2007-10-26 | Bestätigt | Roth Capital | Buy |
Alle ansehen
Trinity Biotech Plc Adr Aktie (TRIB) Neueste Nachrichten
TRIB Stock Chart | TRINITY BIOTECH PLC-SPON ADR (NASDAQ:TRIB) - ChartMill
Number of shareholders of Trinity Biotech plc ADR – FWB:TRB0 - TradingView
Trinity Biotech (TRIB) 10K Form and Latest SEC Filings 2026 - MarketBeat
Trinity Biotech names Jerry Lydon head of North America operations - Investing.com
Trinity Biotech plc Stock: Navigating Challenges in the Diagnostics Sector Amid Market Volatility - AD HOC NEWS
Trinity Biotech reports clinical study results for prostate test By Investing.com - Investing.com South Africa
Trinity Biotech reports clinical study results for prostate test - Investing.com
Trinity Biotech advances CGM+ device toward pivotal trial - Investing.com
Trinity Biotech secures $25M equity financing facility - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewswire Inc.
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Trinity Biotech (TRIB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $TRIB - MarketBeat
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
Should I buy Trinity Biotech (TRIB) - Zacks Investment Research
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
India Heart Failure POC & LOC Devices Market Size & Outlook, 2030 - Grand View Research
South Africa Heart Failure POC & LOC Devices Market Size & Outlook, 2030 - Grand View Research
Denmark Heart Failure POC & LOC Devices Market Size & Outlook, 2030 - Grand View Research
India Hba1c Testing Devices Market Size & Outlook, 2024-2030 - Grand View Research
Canada Lyme Disease Testing Market Size & Outlook, 2024-2030 - Grand View Research
Saudi Arabia Lyme Disease Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Finanzdaten der Trinity Biotech Plc Adr-Aktie (TRIB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):